Company / Operating Income per Share
Insulet Corporation Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$6.75
FY2025
5-year range
$0.74 / $6.75
FY2021-FY2025
Trend
+52.8%
vs FY2024
Sector context
#31 of 154
Health Care
What the data says
Insulet Corporation's operating income per share of $6.75 is higher than 80% of companies in the Health Care sector (FY2025). Operating Income per Share has increased for 3 consecutive years, from $0.74 in FY2022 to $6.75 in FY2025.
Based on SEC 10-K filings.
6.75 in FY2025 with a 5-year CAGR of +72.9%. Top quartile in the Health Care sector.
Improved from $3.17 to $6.75 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +108.5%
- 5-Year CAGR
- +72.9%
- 10-Year CAGR
- -
Sector benchmark
+57.5% above sector average
Key checks
Key Insights
- Insulet Corporation's operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 52.8% year-over-year.
- Ranks #31 out of 154 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.75 | +52.8% |
| FY2024 | $4.42 | +39.6% |
| FY2023 | $3.17 | +325.3% |
| FY2022 | $0.74 | -1.7% |
| FY2021 | $0.76 | +73.3% |
| FY2020 | $0.44 | +449.6% |
| FY2019 | -$0.13 | -126.6% |
| FY2018 | $0.47 | +464.8% |
| FY2017 | -$0.13 | +31.5% |
| FY2016 | -$0.19 | +78.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026